Distraction With Virtual Reality From Pain and Anxiety for Patients With Hematological Malignancies

NARecruitingINTERVENTIONAL
Enrollment

365

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Pain ManagementAnxietyProceduresHematological Neoplasms
Interventions
DEVICE

VR session

"Standard care: Standard care. In both the external control group and the intervention group during Period 1, painful procedures will be performed ccording to usual clinical practice by trained healthcare professionals.~VR session: The device includes a VR headset connected to a smartphone, which displays immersive visual content, along with headphones that deliver audio content. Scenarios are culturally and demographically adapted to the study population. The duration of each VR session will correspond to the time required for each painful procedure."

Trial Locations (1)

3002

RECRUITING

Clinical hematology department of unversity hospital of Hedi Chaker of Sfax, Tunisia, Tunis

All Listed Sponsors
collaborator

University of Sfax

OTHER

lead

Yesmine Amara

OTHER